Replimune (REPL) Total Liabilities (2018 - 2026)

Replimune has reported Total Liabilities for 9 years, with the latest figure at $166.2 million in Q1 2026.

• Quarterly Total Liabilities rose 22.69% year-over-year to $166.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $166.2 million (up 22.69% YoY) and the FY2026 annual result came in at $166.2 million, up 22.69% from the prior year.
• Total Liabilities advanced to $166.2 million in Q1 2026 per REPL's latest filing, from $123.1 million in the prior quarter.
• Over five years, Total Liabilities peaked at $166.2 million in Q1 2026 and troughed at $49.2 million in Q2 2022.
• A 5-year average of $104.0 million and a median of $111.4 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities jumped 86.89% in 2023, then climbed 1.48% in 2025.
• Over 5 years, Total Liabilities stood at $83.2 million in 2022, then soared by 33.88% to $111.4 million in 2023, then increased by 8.85% to $121.3 million in 2024, then gained by 1.48% to $123.1 million in 2025, then surged by 35.09% to $166.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $166.2 million, $123.1 million, and $126.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.